Insights

European Expansion Diabeloop has successfully launched its automated insulin delivery systems in several European countries, presenting a significant sales opportunity to further penetrate the European market.

International Partnerships Strategic partnerships with companies like Novo Nordisk, EOFlow, and SOOIL Development Company provide Diabeloop with access to new markets and customer bases, enhancing sales growth potential globally.

Series C Funding The substantial funding of $75.1M in Series C indicates investor confidence in Diabeloop's AI-based diabetes management solutions, signaling a strong position to drive sales expansion and product development.

Hybrid Product Launches Diabeloop's collaboration with industry players like DexCom, ViCentra, and Eoflow to launch innovative hybrid closed-loop systems presents opportunities for cross-selling, tapping into new customer segments, and increasing sales revenue.

Revenue Potential With a revenue range of $10M - $50M and a focus on intelligent therapeutic solutions for diabetes, Diabeloop represents a lucrative sales opportunity for medical equipment distributors looking to offer cutting-edge technologies in diabetes management.

Diabeloop Tech Stack

Diabeloop uses 8 technology products and services including TrackJS, Docker, Module Federation, and more. Explore Diabeloop's tech stack below.

  • TrackJS
    Analytics
  • Docker
    Containerization
  • Module Federation
    Development
  • Gerrit
    Development
  • Wireshark
    IT Infrastructure Monitoring
  • React
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • React Native
    Widgets

Media & News

Diabeloop's Email Address Formats

Diabeloop uses at least 2 format(s):
Diabeloop Email FormatsExamplePercentage
First.Last@diabeloop.frJohn.Doe@diabeloop.fr
84%
First@diabeloop.frJohn@diabeloop.fr
13%
First.Middle@diabeloop.frJohn.Michael@diabeloop.fr
1%
Last.First@diabeloop.frDoe.John@diabeloop.fr
1%
FirstLast@diabeloop.frJohnDoe@diabeloop.fr
1%

Frequently Asked Questions

Where is Diabeloop's headquarters located?

Minus sign iconPlus sign icon
Diabeloop's main headquarters is located at 17, Rue Félix Esclangon Grenoble, Auvergne-Rhône-Alpes 38000 FR. The company has employees across 2 continents, including EuropeNorth America.

What is Diabeloop's official website and social media links?

Minus sign iconPlus sign icon
Diabeloop's official website is diabeloop.com and has social profiles on LinkedIn.

How much revenue does Diabeloop generate?

Minus sign iconPlus sign icon
As of November 2024, Diabeloop's annual revenue reached $15M.

What is Diabeloop's NAICS code?

Minus sign iconPlus sign icon
Diabeloop's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Diabeloop have currently?

Minus sign iconPlus sign icon
As of November 2024, Diabeloop has approximately 107 employees across 2 continents, including EuropeNorth America. Key team members include Chief Commercial Officer: C. F. G.Head Of Therapy Development: C. B.Chairman & Chief Executive Officer: F. M.. Explore Diabeloop's employee directory with LeadIQ.

What industry does Diabeloop belong to?

Minus sign iconPlus sign icon
Diabeloop operates in the Medical Equipment Manufacturing industry.

What technology does Diabeloop use?

Minus sign iconPlus sign icon
Diabeloop's tech stack includes TrackJSDockerModule FederationGerritWiresharkReactjQuery MigrateReact Native.

What is Diabeloop's email format?

Minus sign iconPlus sign icon
Diabeloop's email format typically follows the pattern of . Find more Diabeloop email formats with LeadIQ.

How much funding has Diabeloop raised to date?

Minus sign iconPlus sign icon
As of November 2024, Diabeloop has raised $16M in funding. The last funding round occurred on Mar 04, 2024 for $16M.

When was Diabeloop founded?

Minus sign iconPlus sign icon
Diabeloop was founded in 2015.
Diabeloop

Diabeloop

Medical Equipment ManufacturingAuvergne-Rhône-Alpes, France51-200 Employees

We want to provide people living with diabetes with an intelligent therapeutic system to regulate blood glucose. 

This project was initiated in 2011 by the CERITD (Centre d’Études et de Recherches pour l’Intensification du Traitement du Diabète) in collaboration with the CEA LETI. After the success of the clinical trials in 2014, we created Diabeloop to bring the project to market and make it available to the largest number of people.

Since spring 2021, DBLG1 System, the first automated insulin delivery device, is being marketed in several European countries: Germany, Italy, Spain, Switzerland, the Netherlands and France.

Section iconCompany Overview

Headquarters
17, Rue Félix Esclangon Grenoble, Auvergne-Rhône-Alpes 38000 FR
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2015
Employees
51-200

Section iconFunding & Financials

  • $16M

    Diabeloop has raised a total of $16M of funding over 6 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $16M.

  • $10M$50M

    Diabeloop's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $16M

    Diabeloop has raised a total of $16M of funding over 6 rounds. Their latest funding round was raised on Mar 04, 2024 in the amount of $16M.

  • $10M$50M

    Diabeloop's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.